AbbVie
ABBV
#25
Rank
ยฃ392.13 B
Marketcap
ยฃ221.85
Share price
-0.59%
Change (1 day)
24.73%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

P/S ratio for AbbVie (ABBV)

P/S ratio as of November 2026 (TTM): 7.84

According to AbbVie's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -87.9. At the end of 2026 the company had a P/S ratio of 7.04.

P/S ratio history for AbbVie from 2012 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20267.046.17%
20256.6318.67%
20245.5810.86%
20235.042.32%
20224.9215.58%
20214.263.14%
20204.134.92%
20193.94-5.43%
20184.16-23.93%
20175.4737.85%
20163.97-4.86%
20154.17-20.04%
20145.2216.95%
20134.4651.93%
20122.94

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.55-67.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
14.6 85.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.37-18.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
3.60-54.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
6.82-13.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.51-68.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.53-42.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.21-71.80%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
4.54-42.14%๐Ÿ‡บ๐Ÿ‡ธ USA